lobbying_activities: 2818909

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2818909	ab4bb536-3e0d-4747-9228-37371421952f	Q2	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2022	second_quarter	MED	AACC joined with other healthcare groups in providing input to the Senate HELP Committee on the provisions in the Food and Drug Administration Safety and Landmark Advances Act pertaining to the Verifying Accurate Leading-edge IVCT Development Act. AACC met with House and Senate staff and conducted a grassroots campaign urging Congress to keep the VALID Act out of the FDASLA legislation.	HOUSE OF REPRESENTATIVES,SENATE		120000	0	0	2022-07-14T12:24:08-04:00